Uncategorized
VIDEO: Anti-VEGFs may eliminate need for PRP in diabetic retinopathy
DENVER — At the Association for Research in Vision and Ophthalmology meeting here, Michael J. Ellman, MD, discusses a long-term subgroup analysis from the RISE and RIDE trials showing an improvement in diabetic retinopathy grading from anti-VEGF treatment that may eliminate the need for pan-retinal photocoagulation laser treatment.